Keyphrases
Cystic Fibrosis
100%
Living with
60%
Elexacaftor-tezacaftor-ivacaftor
50%
Health Registries
25%
Matched Cohort Study
25%
Danish National Patient Registry
25%
Validation Studies
25%
Healthcare Resource Utilization
25%
Hospitalization
25%
Universal Health Care
25%
Healthcare Settings
25%
Maintenance Therapy
25%
Australia
25%
Hospital Contacts
16%
Positive Predictive Value
14%
Minimum number
10%
Odds Ratio
8%
Gastrointestinal
8%
Airway
8%
Valuable Resources
7%
Societal Impacts
6%
Pharmacy
6%
Blood Samples
6%
Number of Days
5%
Medicine and Dentistry
Cystic Fibrosis
100%
Tezacaftor
50%
Ivacaftor
50%
Patient Registry
25%
Cohort Analysis
25%
Universal Health Care
25%
Health Care
25%
Maintenance Therapy
25%
Odds Ratio
8%
Population
7%
Outpatient
6%
Blood Sampling
6%
Logistic Regression Analysis
6%
Nursing and Health Professions
Cystic Fibrosis
50%
Health Care
25%
Ivacaftor
25%
Tezacaftor
25%
Universal Health Care
25%
Predictive Value
12%
Outpatient
6%
Blood Sampling
6%